Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a worldwide
prevalence of 25%. In the United States, NAFLD and its subtype, nonalcoholic …

Nonalcoholic fatty liver disease (NAFLD) is defined as the presence of hepatic fat
accumulation after the exclusion of other causes of hepatic steatosis, including other causes …

Abbreviations: AASLD, American Association for the Study of Liver Diseases; AI, artificial
intelligence; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUROC …

Background The incidence of non-alcoholic fatty liver disease (NAFLD) is rapidly increasing
worldwide parallel to the global obesity epidemic. NAFLD encompasses a range of liver …

Background & Aims We explored whether sarcopenia is associated with the histological
severity of non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis …

Adipose tissue and the liver play significant roles in the regulation of whole-body energy
homeostasis, but they have not evolved to cope with the continuous, chronic, nutrient …

Nonalcoholic fatty liver disease (NAFLD) is known as the most common chronic liver
disease in the United States. 1 With the advent of effective antiviral therapy for hepatitis C …

Non-alcoholic fatty liver disease (NAFLD) is a major health issue worldwide, frequently
associated with obesity and type 2 diabetes. Steatosis is the initial stage of the disease …

Non‐alcoholic fatty liver disease (NAFLD) is associated with visceral obesity, insulin
resistance, type 2 diabetes (T2D) and has been often considered as the hepatic expression …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and
encompasses a spectrum of pathology from simple steatosis to inflammation and significant …